首页> 外国专利> STRAIN OF A RECOMBINANT PSEUDO ADENOVIRAL PARTICLE BASED ON HUMAN ADENOVIRUS GENOME OF SEROTYPE 5 Ad5-tetOFF-E3-HA125 SEROTYPE, CARRYING HAEMAGGLUTININ CONSENSUS GENE OF INFLUENZA VIRUS SUBTYPES H1, H2, H5 FOR PRODUCING INFLUENZA IMMUNOGENIC PREPARATIONS, METHOD FOR PRODUCING GENE

STRAIN OF A RECOMBINANT PSEUDO ADENOVIRAL PARTICLE BASED ON HUMAN ADENOVIRUS GENOME OF SEROTYPE 5 Ad5-tetOFF-E3-HA125 SEROTYPE, CARRYING HAEMAGGLUTININ CONSENSUS GENE OF INFLUENZA VIRUS SUBTYPES H1, H2, H5 FOR PRODUCING INFLUENZA IMMUNOGENIC PREPARATIONS, METHOD FOR PRODUCING GENE

机译:基于血清型5 Ad5-tetoff-E3-HA125人血清型人腺病毒基因组的重组伪腺病毒颗粒,携带流感嗜血杆菌凝集素一致的基因H1,H2,H5亚型,用于生产诱导产物

摘要

FIELD: biotechnology; medicine.;SUBSTANCE: invention refers to biotechnology, virology, medicine. Described is a strain of a recombinant pseudo adenoviral particle based on human adenovirus genome 5 of serotype Ad5-tetOFF-E3-HA125 for producing anti-influenza immunogenic preparations, carrying a consensus gene of haemagglutinin virus of influenza A virus subtypes H1, H2, H5 enriched with B and T-cell epitopes of influenza virus with nucleotide sequence SEQ ID NO: 2, wherein the influenza A haemagglutinin consensus sequence gene codes the amino acid sequence SEQ ID NO: 1. Method for preparing a haemagglutinin consensus sequence with the nucleotide sequence SEQ ID NO: 2. Also described is an immunogenic preparation containing a strain of a recombinant pseudo adenoviral particle based on human adenovirus genome 5 of a serotype according to claim 1. for preventing influenza A, caused by subtypes H1, H2 and H5, containing per dose: recombinant pseudo adenoviral particle Ad5-tetOFF-E3-HA125 - 107-109 actuation components. and a pharmaceutically acceptable buffer solution - up to 0.5 ml.;EFFECT: invention extends the range of agents for preventing influenza A.;3 cl, 8 dwg, 1 tbl, 7 ex
机译:领域:生物技术;药物:发明是指生物技术,病毒学,医学。所描述的是一种基于Ad5-tetOFF-E3-HA125血清型的人腺病毒基因组5的重组伪腺病毒颗粒株,用于产生抗流感免疫原性制剂,其携带甲型流感病毒H1,H2,H5亚型的血凝素病毒的共有基因。富含具有核苷酸序列SEQ ID NO:2的流感病毒的B和T细胞表位的抗原,其中A型流感血凝素共有序列基因编码氨基酸序列SEQ ID NO:1。具有该核苷酸序列的血凝素共有序列的制备方法SEQ ID NO:2。还描述了一种免疫原性制剂,其包含基于权利要求1的血清型的人腺病毒基因组5的重组假腺病毒颗粒的菌株,用于预防由亚型H1,H2和H5引起的甲型流感。每剂量:重组伪腺病毒颗粒Ad5-tetOFF-E3-HA125-10 7 -10 9 致动成分。以及最多0.5毫升的可药用缓冲液;效果:本发明扩展了预防A型流感的药物范围; 3 cl,8 dwg,1 tbl,7 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号